FdaApplication
ANDA 219692
Identifiers
- fda_app_no: ANDA219692
Properties
| Property | Value |
|---|---|
| applicant_name | SAGENT PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2025-08-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | NOREPINEPHRINE BITARTRATE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION;INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | NOREPINEPHRINE BITARTRATE | EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) | SOLUTION;INTRAVENOUS |
2 products